{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:12:10Z","timestamp":1783062730913,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81601011"],"award-info":[{"award-number":["81601011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20160345"],"award-info":[{"award-number":["BK20160345"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.clineuro.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:02:17Z","timestamp":1497312137000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction"],"prefix":"10.1016","volume":"160","author":[{"given":"Yuping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juehua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouru","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2017.06.007_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.STR.28.1.95","article-title":"Carotid plaque morphology and clinical events","volume":"28","author":"Hatsukami","year":"1997","journal-title":"Stroke J. Cereb. Circ."},{"issue":"Suppl: S","key":"10.1016\/j.clineuro.2017.06.007_bib0010","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/0021-9150(95)90081-0","article-title":"Vulnerable and dangerous coronary plaques","volume":"118","author":"Schroeder","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arteriosclerosis Thromb. Vasc. Biol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"History of discovery: inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arteriosclerosis Thromb. Vasc. Biol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0025","first-page":"297","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Steffens","year":"2004","journal-title":"Herz"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.ATV.0000191655.87296.ab","article-title":"Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans","volume":"26","author":"Yang","year":"2006","journal-title":"Arteriosclerosis Thromb. Vasc. Biol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0040","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/STROKEAHA.107.513259","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"40","author":"Ballantyne","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0050","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1016\/j.ijcard.2013.07.113","article-title":"High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy","volume":"168","author":"Koenig","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0025-6196(11)60992-0","article-title":"Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review","volume":"82","author":"Garza","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0060","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0065","doi-asserted-by":"crossref","first-page":"11F","DOI":"10.1016\/j.amjcard.2008.04.014","article-title":"Lipoprotein-associated phospholipase A2: a risk marker or a risk factor","volume":"101","author":"Amir","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0070","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/CIRCULATIONAHA.106.671420","article-title":"Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans","volume":"115","author":"Lavi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0075","first-page":"532","article-title":"Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis","volume":"21","author":"Liu","year":"2014","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1373\/clinchem.2008.108886","article-title":"The evolving role of C-reactive protein in atherothrombosis","volume":"55","author":"Devaraj","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0085","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1747-4949.2012.00860.x","article-title":"Improvement in stroke risk prediction: role of C-reactive protein and lipoprotein-associated phospholipase A(2) the women\u2019s health initiative","volume":"9","author":"Wassertheil-Smoller","year":"2012","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0090","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0095","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","article-title":"Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells","volume":"106","author":"Venugopal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/01.RES.0000147309.54227.42","article-title":"C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction","volume":"95","author":"Li","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.HYP.0000130484.20501.df","article-title":"C-reactive protein: risk marker or mediator in atherothrombosis","volume":"44","author":"Jialal","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0110","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.ATV.0000183718.62409.ea","article-title":"C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells","volume":"25","author":"Singh","year":"2005","journal-title":"Arteriosclerosis Thromb. Vasc. Biol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11883-009-0038-2","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"11","author":"Liao","year":"2009","journal-title":"Curr. Atheroscler. Rep."},{"issue":"Pt. 2","key":"10.1016\/j.clineuro.2017.06.007_bib0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/bj3380479","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor","volume":"338","author":"Macphee","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ncpcardio0321","article-title":"Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke","volume":"2","author":"Caslake","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0130","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.112.249854","article-title":"Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation","volume":"32","author":"Gon\u00e7alves","year":"2012","journal-title":"Arteriosclerosis Thromb. Vasc. Biol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4330\/wjc.v7.i10.609","article-title":"Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications","volume":"7","author":"Maiolino","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1034\/j.1600-0854.2003.00078.x","article-title":"Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function","volume":"4","author":"Brown","year":"2003","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/14728222.6.3.309","article-title":"Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque","volume":"6","author":"Suckling","year":"2002","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0155","doi-asserted-by":"crossref","first-page":"E314","DOI":"10.1007\/BF02854902","article-title":"Lipids and lipidomics in brain injury and diseases","volume":"8","author":"Rao","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.013","article-title":"No association between high-sensitivity C-reactive protein and carotid intima-media progression: the APAC study","volume":"26","author":"Wang","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/07853890701645399","article-title":"Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis","volume":"40","author":"Baldassarre","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J. Am. Colloid Cardiol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0175","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/STROKEAHA.107.503193","article-title":"Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques","volume":"39","author":"Mannheim","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target","volume":"25","author":"Zalewski","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0185","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3349\/ymj.2014.55.6.1507","article-title":"Lipoprotein-associated phospholipase A\u2082 is related to plaque stability and is a potential biomarker for acute coronary syndrome","volume":"55","author":"Chung","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/joim.12133","article-title":"Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques","volume":"275","author":"Grufman","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0195","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.108.771899","article-title":"Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque","volume":"118","author":"Serruys","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0200","doi-asserted-by":"crossref","first-page":"e89034","DOI":"10.1371\/journal.pone.0089034","article-title":"Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial","volume":"9","author":"Johnson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clineuro.2017.06.007_bib0205","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease\u2014NEJM","volume":"370","author":"Buszman","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.clineuro.2017.06.007_bib0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O\u2019Donoghue","year":"2014","journal-title":"JAMA J. Am. Med. Assoc."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846717301749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846717301749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T23:20:06Z","timestamp":1535757606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846717301749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"alternative-id":["S0303846717301749"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2017.06.007","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}